. http://lm360.us/Cipullo-neighbour-of-Robishaw-from-Malans?Cumingsgr=229 eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention. . why novartis� landmark cancer drug approval is great news for bluebird . march 2011 (20) . . .